

NCT01483118 comparison:

Summary:
CHIA has 14 criteria while your personal folder has 14 criteria
Total found criteria: 14/14
Total not Found: 0/14
Total Extra: 3
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Patients aged greater than 18 years of age         │ Patients aged greater than 18 years of age         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ability to understand and willingness to comply    │ Ability to understand and willingness to comply    │
│ with the study protocol                            │ with the study protocol                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Written informed consent                           │ Written informed consent                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients meeting the Rotterdam PCOS workshop       │ Patients meeting the Rotterdam PCOS workshop       │
│ criteria for polycystic ovary syndrome, defined by │ criteria for polycystic ovary syndrome, defined by │
│ oligomenorrhea or amenorrhea and at least one of   │ oligomenorrhea or amenorrhea and at least one of   │
│ the following two signs: clinical or biochemical   │ the following two signs: clinical or biochemical   │
│ evidence of hyperandrogenism or ultrasound finding │ evidence of hyperandrogenism or ultrasound finding │
│ of polycystic appearing ovaries                    │ of polycystic appearing ovaries                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current pregnancy or lactation                     │ Current pregnancy or lactation                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver disease or elevated liver enzymes            │ Liver disease or elevated liver enzymes            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Established diagnosis of diabetes mellitus         │ Established diagnosis of diabetes mellitus         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Abnormal serum glucose levels either at fasting or │ Abnormal serum glucose levels either at fasting or │
│ after the 2-hr oral glucose tolerance test meeting │ after the 2-hr oral glucose tolerance test meeting │
│ criteria for the diagnosis of diabetes mellitus    │ criteria for the diagnosis of diabetes mellitus    │
│ according to the American Diabetes Association     │ according to the American Diabetes Association     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Insulin sensitizing treatment within 3 months      │ Insulin sensitizing treatment within 3 months      │
│ prior to or during the eight week study period     │ prior to or during the eight week study period     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hormonal treatment involving estrogen or           │ Hormonal treatment involving estrogen or           │
│ progesterone 3 months prior to or during the study │ progesterone 3 months prior to or during the study │
│ period, with the exception of medroxyprogesterone  │ period, with the exception of medroxyprogesterone  │
│ acetate for withdrawal bleeding                    │ acetate for withdrawal bleeding                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Systemic or inhaled corticosteroids                │ Systemic or inhaled corticosteroids                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known hypersensitive reaction to cinnamon          │ Known hypersensitive reaction to cinnamon          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with seizure disorders, known             │ Patients with seizure disorders, known             │
│ cardiovascular disease, or cerebrovascular disease │ cardiovascular disease, or cerebrovascular disease │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Body mass index (BMI)range 20-50 (excluding all    │ Body mass index (BMI)range 20-50 (excluding all    │
│ women with BMI under 20 or over 50)                │ women with BMI under 20 or over 50)                │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 38 Years │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
├───────────────────────────────────┤
│ Must be FEMALE                    │
╘═══════════════════════════════════╛